Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 6 Months Ended |
Jun. 30, 2019 | Jun. 30, 2018 | Jun. 30, 2019 | Jun. 30, 2018 |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Total Operating Expenses | | $ 3,566,859 | | $ 3,273,146 | $ 6,748,971 | | $ 6,079,720 |
Stock-Based Compensation Expenses | | $ 38,566 | | 31,804 | $ 77,653 | | 67,289 |
Common Shares Available for Grant | | 13,000,000 | | | 13,000,000 | | |
Stock Options and SARs | | | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Stock-based compensation expense related to stock options, SAR and ESPP grants | | $ 13,600 | | $ 11,700 | $ 27,500 | | $ 23,700 |
Unrecognized compensation expense | [1] | $ 81,300 | | | $ 81,300 | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | | 1 year 7 months 6 days | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | | $ 25.68 | | $ 29.18 |
Expected Volatility (in hundredths) | | | | | 31.50% | | 28.88% |
Risk-Free Interest Rate (in hundredths) | | | | | 2.38% | | 2.23% |
Dividend Yield (in hundredths) | | | | | 0.96% | | 0.67% |
Expected Life (in years) | | | | | 5 years 1 month 6 days | | 5 years |
Stock Options and SARs Rollforward [Abstract] | | | | | | | |
Outstanding at January 1 (in shares) | | | | | 8,310,000 | | 9,103,000 |
Granted (in shares) | | | | | 32,000 | | 32,000 |
Exercised (1) (in shares) | [1] | | | | (157,000) | | (1,662,000) |
Forfeited (in shares) | | | | | (107,000) | | (124,000) |
Outstanding at June 30 (2) (in shares) | [2] | 8,078,000 | | 7,349,000 | 8,078,000 | | 7,349,000 |
Stock Options and SARs Vested or Expected to Vest (3) (in shares) | [3] | 7,741,000 | | 7,006,000 | 7,741,000 | | 7,006,000 |
Stock Options and SARs Exercisable at March 31 (4) (in shares) | [4] | 3,905,000 | | 2,938,000 | 3,905,000 | | 2,938,000 |
Intrinsic Value of Stock Options/SARs Exercised | [1] | | | | $ 3,900 | | $ 74,500 |
Weighted Average Remaining Contractual Life for Stock Options/SARs Outstanding (in years) | | | | | 4 years | | 4 years 3 months 18 days |
Intrinsic Value of Stock Options/SARs Vested or Expected to Vest | [1] | $ 44,400 | | $ 266,200 | $ 44,400 | | $ 266,200 |
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) | | | | | 3 years 10 months 24 days | | 4 years 3 months 18 days |
Aggregate Intrinsic Value for Exercisable Units | [1] | 37,100 | | 134,200 | $ 37,100 | | $ 134,200 |
Weighted average remaining contractual life for exercisable options/SARs (in years) | | | | | 2 years 6 months | | 2 years 8 months 12 days |
Weighted Average Grant Price Stock Option and SARs [Rollforward] | | | | | | | |
Intrinsic Value of Stock Options/SARs Outstanding | [1] | $ 45,000 | | $ 277,200 | $ 45,000 | | $ 277,200 |
Outstanding at January 1 (price per share) | | | | | $ 96.90 | | $ 83.89 |
Granted (price per share) | | | | | 93.29 | | 110.17 |
Exercised (1) (price per share) | [1] | | | | 73.39 | | 71.33 |
Forfeited (price per share) | | | | | 105.47 | | 92.07 |
Outstanding at June 30 (2) (price per share) | [2] | $ 97.23 | | $ 86.71 | 97.23 | | 86.71 |
Vested or Expected to Vest (3) (price per share) | [3] | 96.78 | | 86.44 | 96.78 | | 86.44 |
Exercisable at June 30 (4) (price per share) | [4] | $ 86.71 | | $ 78.74 | 86.71 | | 78.74 |
ESPP | | | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | | $ 22.98 | | $ 23.27 |
Expected Volatility (in hundredths) | | | | | 36.31% | | 22.04% |
Risk-Free Interest Rate (in hundredths) | | | | | 2.48% | | 1.60% |
Dividend Yield (in hundredths) | | | | | 0.83% | | 0.66% |
Expected Life (in years) | | | | | 15 days | | 15 days |
Restricted Stock And Restricted Stock Units | | | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Unrecognized compensation expense | [1] | $ 158,200 | | | $ 158,200 | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | | 1 year 8 months 12 days | | |
Intrinsic value released during the year | [1] | | | | $ 35,700 | | $ 34,900 |
Aggregate intrinsic value of stock and units outstanding | [1] | 347,500 | | $ 468,200 | 347,500 | | 468,200 |
Restricted Stock/Restricted Stock Units [Roll Forward] | | | | | | | |
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost | [1] | $ 23,100 | | $ 19,000 | $ 46,400 | | $ 41,300 |
Outstanding at January 1 (in shares) | | | | | 3,792,000 | | 3,905,000 |
Granted (in shares) | | | | | 401,000 | | 309,000 |
Released (1) (in shares) | [5] | | | | (395,000) | | (331,000) |
Forfeited (in shares) | | | | | (68,000) | | (120,000) |
Outstanding at June 30 (2) (in shares) | [6] | 3,730,000 | | 3,763,000 | 3,730,000 | | 3,763,000 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward] | | | | | | | |
Outstanding at January 1 (price per share) | | | | | $ 96.64 | | $ 88.57 |
Granted (price per share) | | | | | 96.22 | | 103.52 |
Released (1) (price per share) | [5] | | | | 93.84 | | 69.55 |
Forfeited (price per share) | | | | | 98.27 | | 91.28 |
Outstanding at June 30 (2) (price per share) | [6] | $ 96.86 | | $ 91.39 | $ 96.86 | | $ 91.39 |
Performance Unit | | | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Stock-Based Compensation Expenses | [1] | $ 1,900 | | $ 1,100 | $ 3,800 | | $ 2,300 |
Unrecognized compensation expense | | 6,000 | | | $ 6,000 | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | | 1 year 2 months 12 days | | |
Intrinsic value released during the year | [1] | | | | $ 7,700 | | |
Aggregate intrinsic value of stock and units outstanding | | $ 49,200 | | $ 71,400 | $ 49,200 | | $ 71,400 |
Minimum Performance Units and Stock Allowed to be Outstanding | | | | | 205 | | |
Maximum Performance Units and Stock Allowed to be Outstanding | | | | | 852 | | |
Restricted Stock/Restricted Stock Units [Roll Forward] | | | | | | | |
Outstanding at January 1 (in shares) | | | | | 539 | | 502 |
Granted (in shares) | | | | | 0 | | 0 |
Granted for Performance Multiple (1) | [7] | | | | 72 | | 72 |
Released (1) (in shares) | | | | | 83 | | 0 |
Forfeited (in shares) | | | | | 0 | | 0 |
Outstanding at June 30 (2) (in shares) | [8] | 528 | [9] | 574 | 528 | [9] | 574 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward] | | | | | | | |
Outstanding at January 1 (price per share) | | | | | $ 101.53 | | $ 90.96 |
Granted (price per share) | | | | | 0 | | 0 |
Granted for Performance Multiple (1) (in dollars per share) | [7] | | | | 69.43 | | 101.87 |
Released (1) (price per share) | | | | | 85.65 | | 0 |
Forfeited (price per share) | | | | | 0 | | 0 |
Outstanding at June 30 (2) (price per share) | [8] | $ 99.64 | | $ 92.33 | $ 99.64 | | $ 92.33 |
Performance Units and Performance Stock Disclosures [Abstract] | | | | | | | |
Performance Period for Performance Units and Shares | | 3 years | | | | | |
Minimum Performance Multiple at the Completion of the Performance Period | | 0.00% | | | | | |
Maximum Performance Multiple at the Completion of the Performance Period | | 200.00% | | | 200.00% | | |
Lease and Well | | | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Stock-Based Compensation Expenses | | $ 13,600 | | $ 11,400 | $ 27,300 | | $ 24,200 |
Gathering and Processing Costs | | | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Stock-Based Compensation Expenses | | 300 | | 100 | 500 | | 200 |
Exploration Costs | | | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Stock-Based Compensation Expenses | | 6,500 | | 5,700 | 13,000 | | 12,600 |
General and Administrative | | | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Stock-Based Compensation Expenses | | $ 18,200 | | $ 14,600 | $ 36,900 | | $ 30,300 |
| |
[1] | The total intrinsic value of stock options/SARs exercised during the six months ended June 30, 2019 and 2018 was $3.9 million and $74.5 million , respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs. | |
[2] | The total intrinsic value of stock options/SARs outstanding at June 30, 2019 and 2018 was $45.0 million and $277.2 million , respectively. At June 30, 2019 and 2018 , the weighted average remaining contractual life was 4.0 years and 4.3 years , respectively. | |
[3] | The total intrinsic value of stock options/SARs vested or expected to vest at June 30, 2019 and 2018 was $44.4 million and $266.2 million , respectively. At June 30, 2019 and 2018 , the weighted average remaining contractual life was 3.9 years and 4.3 years , respectively. | |
[4] | The total intrinsic value of stock options/SARs exercisable at June 30, 2019 and 2018 was $37.1 million and $134.2 million , respectively. At June 30, 2019 and 2018 , the weighted average remaining contractual life was 2.5 years and 2.7 years , respectively. | |
[5] | The total intrinsic value of restricted stock and restricted stock units released during the six months ended June 30, 2019 and 2018 was $35.7 million and $34.9 million , respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released. | |
[6] | The total intrinsic value of restricted stock and restricted stock units outstanding at June 30, 2019 and 2018 was $347.5 million and $468.2 million , respectively. | |
[7] | Upon completion of the Performance Period for the performance units granted in 2015 and 2014, a performance multiple of 200% was applied to each of the grants resulting in additional grants of performance units in February 2019 and February 2018, respectively. | |
[8] | The total intrinsic value of performance units outstanding at June 30, 2019 and 2018 was approximately $49.2 million and $71.4 million , respectively. | |
[9] | Upon the application of the relevant performance multiple at the completion of each of the remaining Performance Periods, a minimum of 205 and a maximum of 852 performance units could be outstanding. | |